Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 7.01535125 |
2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.71891864 |
3 | neutrophil activation involved in immune response (GO:0002283) | 4.65415058 |
4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.65249904 |
5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.65249904 |
6 | immunoglobulin mediated immune response (GO:0016064) | 4.52992284 |
7 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.41349706 |
8 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.33432456 |
9 | leukocyte aggregation (GO:0070486) | 4.30224932 |
10 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.26103396 |
11 | modulation by symbiont of host immune response (GO:0052553) | 4.24033690 |
12 | positive regulation by symbiont of host defense response (GO:0052509) | 4.24033690 |
13 | modulation by symbiont of host defense response (GO:0052031) | 4.24033690 |
14 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.24033690 |
15 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.24033690 |
16 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.24033690 |
17 | mast cell activation (GO:0045576) | 4.04755844 |
18 | respiratory burst (GO:0045730) | 3.87637428 |
19 | T cell migration (GO:0072678) | 3.82979054 |
20 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.80546317 |
21 | response to peptidoglycan (GO:0032494) | 3.74772290 |
22 | defense response to protozoan (GO:0042832) | 3.68712162 |
23 | positive regulation of interferon-alpha production (GO:0032727) | 3.67420816 |
24 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.66022479 |
25 | B cell mediated immunity (GO:0019724) | 3.62011251 |
26 | cellular response to type I interferon (GO:0071357) | 3.58707082 |
27 | type I interferon signaling pathway (GO:0060337) | 3.58707082 |
28 | response to type I interferon (GO:0034340) | 3.57446174 |
29 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.56506951 |
30 | regulation of interferon-alpha production (GO:0032647) | 3.53232266 |
31 | response to protozoan (GO:0001562) | 3.52662776 |
32 | response to interferon-beta (GO:0035456) | 3.50827027 |
33 | myeloid dendritic cell activation (GO:0001773) | 3.50780338 |
34 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.49870417 |
35 | interferon-gamma production (GO:0032609) | 3.43659566 |
36 | regulation of B cell differentiation (GO:0045577) | 3.40761598 |
37 | myeloid cell activation involved in immune response (GO:0002275) | 3.39016360 |
38 | cellular extravasation (GO:0045123) | 3.34004232 |
39 | myeloid dendritic cell differentiation (GO:0043011) | 3.32035057 |
40 | neutrophil activation (GO:0042119) | 3.31680744 |
41 | positive regulation of B cell differentiation (GO:0045579) | 3.30108123 |
42 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.30016470 |
43 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.25855780 |
44 | granulocyte activation (GO:0036230) | 3.24023393 |
45 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.23676604 |
46 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.23505510 |
47 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.23101330 |
48 | negative regulation of cell killing (GO:0031342) | 3.21016663 |
49 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.21016663 |
50 | regulation of gamma-delta T cell activation (GO:0046643) | 3.19565225 |
51 | cellular response to interferon-beta (GO:0035458) | 3.18774092 |
52 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.18516701 |
53 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.16671152 |
54 | regulation of regulatory T cell differentiation (GO:0045589) | 3.16161745 |
55 | positive regulation of macrophage differentiation (GO:0045651) | 3.14886240 |
56 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.13823061 |
57 | negative thymic T cell selection (GO:0045060) | 3.12971668 |
58 | macrophage activation involved in immune response (GO:0002281) | 3.11873872 |
59 | autophagic vacuole fusion (GO:0000046) | 3.11706333 |
60 | positive regulation of mast cell activation (GO:0033005) | 3.10773660 |
61 | negative T cell selection (GO:0043383) | 3.09442515 |
62 | response to interferon-alpha (GO:0035455) | 3.09306401 |
63 | cellular response to zinc ion (GO:0071294) | 3.08434514 |
64 | negative regulation of T cell mediated immunity (GO:0002710) | 3.07775062 |
65 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.06063317 |
66 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.06058563 |
67 | negative regulation of interleukin-12 production (GO:0032695) | 3.03571885 |
68 | positive regulation of B cell mediated immunity (GO:0002714) | 3.00213089 |
69 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.00213089 |
70 | NIK/NF-kappaB signaling (GO:0038061) | 2.99717998 |
71 | thymic T cell selection (GO:0045061) | 2.99003179 |
72 | positive regulation of isotype switching (GO:0045830) | 2.98652200 |
73 | positive regulation of interleukin-17 production (GO:0032740) | 2.98188600 |
74 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.98041876 |
75 | positive regulation of antigen processing and presentation (GO:0002579) | 2.97258176 |
76 | sequestering of actin monomers (GO:0042989) | 2.94691730 |
77 | positive regulation of granulocyte differentiation (GO:0030854) | 2.94154641 |
78 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.94116182 |
79 | actin nucleation (GO:0045010) | 2.93975353 |
80 | positive T cell selection (GO:0043368) | 2.93500214 |
81 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.93123673 |
82 | T cell selection (GO:0045058) | 2.91995483 |
83 | B cell receptor signaling pathway (GO:0050853) | 2.91068231 |
84 | leukocyte cell-cell adhesion (GO:0007159) | 2.90383236 |
85 | tolerance induction (GO:0002507) | 2.89970557 |
86 | cellular response to interleukin-15 (GO:0071350) | 2.89968168 |
87 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.89319900 |
88 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.88836373 |
89 | ribosomal small subunit assembly (GO:0000028) | 2.87977480 |
90 | positive thymic T cell selection (GO:0045059) | 2.87531165 |
91 | negative regulation of phagocytosis (GO:0050765) | 2.87326138 |
92 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.87092845 |
93 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.87092845 |
94 | response to interleukin-15 (GO:0070672) | 2.87075670 |
95 | mast cell activation involved in immune response (GO:0002279) | 2.86829787 |
96 | mast cell degranulation (GO:0043303) | 2.86829787 |
97 | regulation of mast cell activation (GO:0033003) | 2.86669057 |
98 | leukocyte degranulation (GO:0043299) | 2.85847283 |
99 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.84850277 |
100 | detection of bacterium (GO:0016045) | 2.83625563 |
101 | myeloid leukocyte activation (GO:0002274) | 2.83174527 |
102 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.83146204 |
103 | response to host immune response (GO:0052572) | 2.83146204 |
104 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.81199014 |
105 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.81111494 |
106 | regulation of T cell tolerance induction (GO:0002664) | 2.80639838 |
107 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.80110072 |
108 | regulation of hypersensitivity (GO:0002883) | 2.78954650 |
109 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.78876817 |
110 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.78667301 |
111 | response to muramyl dipeptide (GO:0032495) | 2.77432600 |
112 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.76499002 |
113 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.76462458 |
114 | regulation of chemokine biosynthetic process (GO:0045073) | 2.76095966 |
115 | regulation of mast cell degranulation (GO:0043304) | 2.75602042 |
116 | positive regulation of interferon-beta production (GO:0032728) | 2.74213417 |
117 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.73587840 |
118 | detection of other organism (GO:0098543) | 2.72862041 |
119 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.72649603 |
120 | negative regulation of innate immune response (GO:0045824) | 2.72075081 |
121 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.71646505 |
122 | germinal center formation (GO:0002467) | 2.70679951 |
123 | regulation of antigen processing and presentation (GO:0002577) | 2.70496399 |
124 | dendritic cell differentiation (GO:0097028) | 2.69773609 |
125 | positive regulation of mast cell degranulation (GO:0043306) | 2.69516989 |
126 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.69516989 |
127 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.64493465 |
128 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.64165655 |
129 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.63476400 |
130 | organelle membrane fusion (GO:0090174) | 2.62596678 |
131 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.62046513 |
132 | megakaryocyte development (GO:0035855) | 2.61929291 |
133 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.61474125 |
134 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.58488422 |
135 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.58471643 |
136 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.57569505 |
137 | regulation of T cell apoptotic process (GO:0070232) | 2.56526858 |
138 | negative regulation of T cell apoptotic process (GO:0070233) | 2.55878441 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.59607082 |
2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.31351087 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.04740649 |
4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.27937084 |
5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.01174288 |
6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.85982570 |
7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.73495639 |
8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.25433801 |
9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.19228773 |
10 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.15731503 |
11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.15716579 |
12 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.96918595 |
13 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.95316375 |
14 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.92636912 |
15 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.87376600 |
16 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.85102836 |
17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.78153921 |
18 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.77862682 |
19 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.61287982 |
20 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.58057439 |
21 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.42273071 |
22 | MYB_26560356_Chip-Seq_TH2_Human | 2.38010691 |
23 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.26883932 |
24 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.19646094 |
25 | MAF_26560356_Chip-Seq_TH1_Human | 2.15333158 |
26 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.12950301 |
27 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.09458394 |
28 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.09171414 |
29 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.07105140 |
30 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.05721392 |
31 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.00735683 |
32 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.00697983 |
33 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.00437239 |
34 | MYC_22102868_ChIP-Seq_BL_Human | 1.95419839 |
35 | * MYB_26560356_Chip-Seq_TH1_Human | 1.92839608 |
36 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92595819 |
37 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.89639645 |
38 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.88553583 |
39 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80638848 |
40 | UTX_26944678_Chip-Seq_JUKART_Human | 1.78347840 |
41 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.69101953 |
42 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67093412 |
43 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.66863170 |
44 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66203258 |
45 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.64849869 |
46 | SPI1_23127762_ChIP-Seq_K562_Human | 1.60455407 |
47 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.53981439 |
48 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.50555472 |
49 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.46236495 |
50 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.46160747 |
51 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.45412201 |
52 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.43741954 |
53 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.42973210 |
54 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.42932970 |
55 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.39274641 |
56 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.38994266 |
57 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.37802570 |
58 | MAF_26560356_Chip-Seq_TH2_Human | 1.35947061 |
59 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.35033336 |
60 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.33593854 |
61 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.31480998 |
62 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.30914827 |
63 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.30213788 |
64 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.29244177 |
65 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.26394605 |
66 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.23885912 |
67 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.23424732 |
68 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.22815782 |
69 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22010961 |
70 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20435505 |
71 | GATA3_26560356_Chip-Seq_TH2_Human | 1.18167964 |
72 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.16215919 |
73 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.15689153 |
74 | GATA1_19941826_ChIP-Seq_K562_Human | 1.14618940 |
75 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13352371 |
76 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10740479 |
77 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10264959 |
78 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.07645676 |
79 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.06483177 |
80 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.05980657 |
81 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.05801684 |
82 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.05769343 |
83 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.05739948 |
84 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05655559 |
85 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.04989824 |
86 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.02623891 |
87 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.02116196 |
88 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01755789 |
89 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.01681248 |
90 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.98988187 |
91 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.98517718 |
92 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.97440911 |
93 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.97372172 |
94 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.96411702 |
95 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.92403293 |
96 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.92331197 |
97 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.90626113 |
98 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.90167827 |
99 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.89892838 |
100 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.89859725 |
101 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.88482575 |
102 | GATA1_22025678_ChIP-Seq_K562_Human | 0.87507494 |
103 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.87405922 |
104 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.85670509 |
105 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.82013488 |
106 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.81875052 |
107 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.81522907 |
108 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78035212 |
109 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.75202087 |
110 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.74906272 |
111 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.74034375 |
112 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.72535413 |
113 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.72037021 |
114 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.71735043 |
115 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.70965777 |
116 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.69569498 |
117 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.68520658 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 4.60908312 |
2 | MP0009785_altered_susceptibility_to | 3.72812807 |
3 | MP0003436_decreased_susceptibility_to | 3.65860267 |
4 | MP0005671_abnormal_response_to | 3.61427881 |
5 | MP0002148_abnormal_hypersensitivity_rea | 3.25188907 |
6 | MP0005000_abnormal_immune_tolerance | 3.15844957 |
7 | MP0005025_abnormal_response_to | 3.06630977 |
8 | MP0000685_abnormal_immune_system | 3.00201335 |
9 | MP0003724_increased_susceptibility_to | 2.99091159 |
10 | MP0002419_abnormal_innate_immunity | 2.96543225 |
11 | MP0001800_abnormal_humoral_immune | 2.79077760 |
12 | MP0002452_abnormal_antigen_presenting | 2.75895712 |
13 | MP0006082_CNS_inflammation | 2.74382654 |
14 | MP0001790_abnormal_immune_system | 2.73008212 |
15 | MP0005387_immune_system_phenotype | 2.73008212 |
16 | MP0002723_abnormal_immune_serum | 2.71000573 |
17 | MP0002420_abnormal_adaptive_immunity | 2.62204351 |
18 | MP0001819_abnormal_immune_cell | 2.61956338 |
19 | MP0003763_abnormal_thymus_physiology | 2.53357160 |
20 | MP0003303_peritoneal_inflammation | 2.40032149 |
21 | MP0005464_abnormal_platelet_physiology | 2.36470715 |
22 | MP0009333_abnormal_splenocyte_physiolog | 2.34929070 |
23 | MP0002405_respiratory_system_inflammati | 2.29644414 |
24 | MP0002398_abnormal_bone_marrow | 2.18181261 |
25 | MP0002166_altered_tumor_susceptibility | 2.16963339 |
26 | MP0001853_heart_inflammation | 2.11109942 |
27 | MP0002396_abnormal_hematopoietic_system | 2.10138293 |
28 | MP0002006_tumorigenesis | 2.06983668 |
29 | MP0000716_abnormal_immune_system | 2.06506489 |
30 | MP0010155_abnormal_intestine_physiology | 1.99493799 |
31 | MP0004510_myositis | 1.93096194 |
32 | MP0001845_abnormal_inflammatory_respons | 1.90116136 |
33 | MP0005058_abnormal_lysosome_morphology | 1.89775508 |
34 | MP0001533_abnormal_skeleton_physiology | 1.87299408 |
35 | MP0000689_abnormal_spleen_morphology | 1.84611042 |
36 | MP0002722_abnormal_immune_system | 1.79481123 |
37 | MP0002429_abnormal_blood_cell | 1.73539873 |
38 | MP0004947_skin_inflammation | 1.71402490 |
39 | MP0001873_stomach_inflammation | 1.65770925 |
40 | MP0005397_hematopoietic_system_phenotyp | 1.65533103 |
41 | MP0001545_abnormal_hematopoietic_system | 1.65533103 |
42 | MP0003806_abnormal_nucleotide_metabolis | 1.62628927 |
43 | MP0000343_altered_response_to | 1.62351310 |
44 | MP0004808_abnormal_hematopoietic_stem | 1.58946847 |
45 | MP0000465_gastrointestinal_hemorrhage | 1.58535338 |
46 | MP0008469_abnormal_protein_level | 1.55453855 |
47 | MP0003448_altered_tumor_morphology | 1.54559535 |
48 | MP0002933_joint_inflammation | 1.51124929 |
49 | MP0005174_abnormal_tail_pigmentation | 1.50492771 |
50 | MP0002877_abnormal_melanocyte_morpholog | 1.49831625 |
51 | MP0000858_altered_metastatic_potential | 1.48770552 |
52 | MP0003300_gastrointestinal_ulcer | 1.47802989 |
53 | MP0000490_abnormal_crypts_of | 1.44212150 |
54 | MP0005310_abnormal_salivary_gland | 1.43700852 |
55 | MP0003866_abnormal_defecation | 1.41818302 |
56 | MP0003172_abnormal_lysosome_physiology | 1.41067494 |
57 | MP0000703_abnormal_thymus_morphology | 1.38680899 |
58 | MP0009764_decreased_sensitivity_to | 1.38671852 |
59 | MP0009278_abnormal_bone_marrow | 1.38080414 |
60 | MP0002998_abnormal_bone_remodeling | 1.25117521 |
61 | MP0001851_eye_inflammation | 1.09482079 |
62 | MP0003191_abnormal_cellular_cholesterol | 1.08791028 |
63 | MP0005075_abnormal_melanosome_morpholog | 1.04790331 |
64 | MP0005166_decreased_susceptibility_to | 1.02477714 |
65 | MP0003075_altered_response_to | 1.00736689 |
66 | MP0003828_pulmonary_edema | 0.98966768 |
67 | MP0002254_reproductive_system_inflammat | 0.97730582 |
68 | MP0009763_increased_sensitivity_to | 0.89097112 |
69 | MP0005390_skeleton_phenotype | 0.88560765 |
70 | MP0000015_abnormal_ear_pigmentation | 0.87382287 |
71 | MP0002019_abnormal_tumor_incidence | 0.86241400 |
72 | MP0010307_abnormal_tumor_latency | 0.83594573 |
73 | MP0002132_abnormal_respiratory_system | 0.83039223 |
74 | MP0000249_abnormal_blood_vessel | 0.78056169 |
75 | MP0004147_increased_porphyrin_level | 0.77115218 |
76 | MP0001542_abnormal_bone_strength | 0.75761194 |
77 | MP0003186_abnormal_redox_activity | 0.75731978 |
78 | MP0003786_premature_aging | 0.75627698 |
79 | MP0004782_abnormal_surfactant_physiolog | 0.74742320 |
80 | MP0005165_increased_susceptibility_to | 0.74222062 |
81 | MP0005167_abnormal_blood-brain_barrier | 0.74132537 |
82 | MP0002095_abnormal_skin_pigmentation | 0.72900352 |
83 | MP0003183_abnormal_peptide_metabolism | 0.72606393 |
84 | MP0001663_abnormal_digestive_system | 0.72379755 |
85 | MP0003795_abnormal_bone_structure | 0.71788669 |
86 | MP0006054_spinal_hemorrhage | 0.68820465 |
87 | MP0000372_irregular_coat_pigmentation | 0.66209852 |
88 | MP0008260_abnormal_autophagy | 0.65193837 |
89 | MP0008004_abnormal_stomach_pH | 0.64799767 |
90 | MP0005023_abnormal_wound_healing | 0.64447014 |
91 | MP0009840_abnormal_foam_cell | 0.62569723 |
92 | MP0005381_digestive/alimentary_phenotyp | 0.62121740 |
93 | MP0000371_diluted_coat_color | 0.61804558 |
94 | MP0005083_abnormal_biliary_tract | 0.61555591 |
95 | MP0004381_abnormal_hair_follicle | 0.59670430 |
96 | MP0005164_abnormal_response_to | 0.59033562 |
97 | MP0008007_abnormal_cellular_replicative | 0.58427013 |
98 | MP0002138_abnormal_hepatobiliary_system | 0.58235720 |
99 | MP0005451_abnormal_body_composition | 0.58180092 |
100 | MP0008873_increased_physiological_sensi | 0.56812523 |
101 | MP0003693_abnormal_embryo_hatching | 0.55106218 |
102 | MP0002277_abnormal_respiratory_mucosa | 0.54856607 |
103 | MP0003566_abnormal_cell_adhesion | 0.54043439 |
104 | MP0003453_abnormal_keratinocyte_physiol | 0.53106529 |
105 | MP0003638_abnormal_response/metabolism_ | 0.52630719 |
106 | MP0010352_gastrointestinal_tract_polyps | 0.52236990 |
107 | MP0002136_abnormal_kidney_physiology | 0.51782102 |
108 | MP0000604_amyloidosis | 0.50164405 |
109 | MP0003279_aneurysm | 0.50152913 |
110 | MP0002693_abnormal_pancreas_physiology | 0.49969001 |
111 | MP0000313_abnormal_cell_death | 0.49291108 |
112 | MP0009765_abnormal_xenobiotic_induced | 0.49265227 |
113 | MP0005319_abnormal_enzyme/_coenzyme | 0.49132332 |
114 | MP0003656_abnormal_erythrocyte_physiolo | 0.47834877 |
115 | MP0004883_abnormal_blood_vessel | 0.44472036 |
116 | MP0003045_fibrosis | 0.42061400 |
117 | MP0008057_abnormal_DNA_replication | 0.41287590 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 6.42164342 |
2 | Eczematoid dermatitis (HP:0000976) | 5.90489686 |
3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.63946792 |
4 | Recurrent bacterial skin infections (HP:0005406) | 5.48004387 |
5 | Myositis (HP:0100614) | 5.12253218 |
6 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.35852103 |
7 | Mediastinal lymphadenopathy (HP:0100721) | 4.23300127 |
8 | Abnormality of macrophages (HP:0004311) | 4.16579781 |
9 | Recurrent fungal infections (HP:0002841) | 4.08190018 |
10 | Stomatitis (HP:0010280) | 4.07882891 |
11 | Orchitis (HP:0100796) | 4.02733851 |
12 | Obstructive lung disease (HP:0006536) | 3.90198999 |
13 | Chronic obstructive pulmonary disease (HP:0006510) | 3.90198999 |
14 | Recurrent skin infections (HP:0001581) | 3.88110530 |
15 | Optic neuritis (HP:0100653) | 3.83978679 |
16 | Retrobulbar optic neuritis (HP:0100654) | 3.83978679 |
17 | Vacuolated lymphocytes (HP:0001922) | 3.82354924 |
18 | IgM deficiency (HP:0002850) | 3.80502853 |
19 | Petechiae (HP:0000967) | 3.51379290 |
20 | Chronic otitis media (HP:0000389) | 3.51134474 |
21 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.45348591 |
22 | Recurrent cutaneous fungal infections (HP:0011370) | 3.45348591 |
23 | Recurrent viral infections (HP:0004429) | 3.40616538 |
24 | Autoimmune thrombocytopenia (HP:0001973) | 3.32888971 |
25 | Gingivitis (HP:0000230) | 3.26693084 |
26 | Meningitis (HP:0001287) | 3.25898485 |
27 | Thrombocytosis (HP:0001894) | 3.25417519 |
28 | Vasculitis (HP:0002633) | 3.23602134 |
29 | Abnormality of T cell number (HP:0011839) | 3.20688861 |
30 | T lymphocytopenia (HP:0005403) | 3.18115235 |
31 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.11397733 |
32 | Abnormality of T cells (HP:0002843) | 3.10324701 |
33 | Recurrent bronchitis (HP:0002837) | 3.08934404 |
34 | Increased cerebral lipofuscin (HP:0011813) | 3.06837776 |
35 | Pustule (HP:0200039) | 3.04649231 |
36 | Cellulitis (HP:0100658) | 2.89000707 |
37 | Spontaneous hematomas (HP:0007420) | 2.88930383 |
38 | Abnormality of T cell physiology (HP:0011840) | 2.85260601 |
39 | Nasal polyposis (HP:0100582) | 2.81470728 |
40 | Interstitial pulmonary disease (HP:0006530) | 2.79881057 |
41 | Abnormality of the nasal mucosa (HP:0000433) | 2.79464220 |
42 | Systemic lupus erythematosus (HP:0002725) | 2.77544643 |
43 | Pulmonary infiltrates (HP:0002113) | 2.76216020 |
44 | Basal ganglia calcification (HP:0002135) | 2.74181132 |
45 | Hemoptysis (HP:0002105) | 2.72972000 |
46 | IgG deficiency (HP:0004315) | 2.71365748 |
47 | Increased IgM level (HP:0003496) | 2.71163574 |
48 | Leukocytosis (HP:0001974) | 2.69962785 |
49 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.65406322 |
50 | Hypergammaglobulinemia (HP:0010702) | 2.64418154 |
51 | Hepatosplenomegaly (HP:0001433) | 2.63996230 |
52 | Prolonged bleeding time (HP:0003010) | 2.63674725 |
53 | Periodontitis (HP:0000704) | 2.60138261 |
54 | Lymphopenia (HP:0001888) | 2.54294175 |
55 | Epistaxis (HP:0000421) | 2.54010831 |
56 | Severe combined immunodeficiency (HP:0004430) | 2.53991138 |
57 | Arterial thrombosis (HP:0004420) | 2.52290267 |
58 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.50173092 |
59 | Autoimmune hemolytic anemia (HP:0001890) | 2.48473055 |
60 | Keratoconjunctivitis sicca (HP:0001097) | 2.48259565 |
61 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.47904788 |
62 | Combined immunodeficiency (HP:0005387) | 2.46826139 |
63 | Abnormality of the prostate (HP:0008775) | 2.46756414 |
64 | Loss of speech (HP:0002371) | 2.45313374 |
65 | Thyroiditis (HP:0100646) | 2.42539239 |
66 | Urticaria (HP:0001025) | 2.41853811 |
67 | Panhypogammaglobulinemia (HP:0003139) | 2.41604526 |
68 | Hypertensive crisis (HP:0100735) | 2.40659171 |
69 | Gingival bleeding (HP:0000225) | 2.38840467 |
70 | Purpura (HP:0000979) | 2.38714744 |
71 | Inflammation of the large intestine (HP:0002037) | 2.38026679 |
72 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.31260645 |
73 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.31260645 |
74 | Abnormality of glycolipid metabolism (HP:0010969) | 2.31260645 |
75 | Gastrointestinal inflammation (HP:0004386) | 2.30044952 |
76 | Increased serum ferritin (HP:0003281) | 2.29764464 |
77 | Dysostosis multiplex (HP:0000943) | 2.28475058 |
78 | Agnosia (HP:0010524) | 2.28055315 |
79 | Recurrent pneumonia (HP:0006532) | 2.27891106 |
80 | Gastrointestinal stroma tumor (HP:0100723) | 2.27008698 |
81 | Polyneuropathy (HP:0001271) | 2.26191076 |
82 | Encephalitis (HP:0002383) | 2.25895924 |
83 | Abnormality of eosinophils (HP:0001879) | 2.24272012 |
84 | Keratoconjunctivitis (HP:0001096) | 2.23474303 |
85 | Joint swelling (HP:0001386) | 2.22463510 |
86 | Chronic diarrhea (HP:0002028) | 2.21372553 |
87 | Episodic fever (HP:0001954) | 2.18057183 |
88 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.17168178 |
89 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.17168178 |
90 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.17168178 |
91 | Glomerulopathy (HP:0100820) | 2.17000702 |
92 | Pulmonary fibrosis (HP:0002206) | 2.14658344 |
93 | Chest pain (HP:0100749) | 2.14248870 |
94 | Reduced antithrombin III activity (HP:0001976) | 2.14207077 |
95 | Poor head control (HP:0002421) | 2.13445036 |
96 | Eosinophilia (HP:0001880) | 2.12624846 |
97 | Pulmonary embolism (HP:0002204) | 2.12136647 |
98 | Osteomyelitis (HP:0002754) | 2.11851992 |
99 | Gangrene (HP:0100758) | 2.11812404 |
100 | Gastrointestinal infarctions (HP:0005244) | 2.10742528 |
101 | Abnormality of B cell number (HP:0010975) | 2.09023039 |
102 | Axonal loss (HP:0003447) | 2.08350019 |
103 | Disinhibition (HP:0000734) | 2.07738774 |
104 | Fatigue (HP:0012378) | 2.07698243 |
105 | Recurrent lower respiratory tract infections (HP:0002783) | 2.06859046 |
106 | Anorexia (HP:0002039) | 2.05688514 |
107 | Agammaglobulinemia (HP:0004432) | 2.05145900 |
108 | Lymphoma (HP:0002665) | 2.03596345 |
109 | Impaired platelet aggregation (HP:0003540) | 2.03002905 |
110 | Abnormal platelet function (HP:0011869) | 2.03002905 |
111 | Aplastic anemia (HP:0001915) | 2.02323215 |
112 | Abnormality of the pleura (HP:0002103) | 2.02240079 |
113 | Abnormality of iron homeostasis (HP:0011031) | 2.02176602 |
114 | Increased IgE level (HP:0003212) | 2.01359684 |
115 | Prostate neoplasm (HP:0100787) | 2.00808674 |
116 | Granulocytopenia (HP:0001913) | 2.00390757 |
117 | Skin ulcer (HP:0200042) | 1.99344322 |
118 | IgA deficiency (HP:0002720) | 1.98608591 |
119 | Albinism (HP:0001022) | 1.97731169 |
120 | Progressive neurologic deterioration (HP:0002344) | 1.97187498 |
121 | Spondylolisthesis (HP:0003302) | 1.96276864 |
122 | Mucopolysacchariduria (HP:0008155) | 1.96010647 |
123 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.96010647 |
124 | Skin rash (HP:0000988) | 1.92833694 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 4.52662560 |
2 | TXK | 3.91401534 |
3 | BLK | 3.23666016 |
4 | KIT | 3.02663442 |
5 | IRAK4 | 3.00711041 |
6 | TBK1 | 2.76340932 |
7 | NME2 | 2.63635556 |
8 | ZAP70 | 2.55377323 |
9 | MAP3K14 | 2.53987319 |
10 | TYK2 | 2.43436446 |
11 | IKBKE | 2.41522347 |
12 | JAK3 | 2.41504086 |
13 | TEC | 2.39450349 |
14 | BTK | 2.19710041 |
15 | PIM2 | 2.14096666 |
16 | RIPK4 | 2.10956262 |
17 | TAOK1 | 1.95298101 |
18 | KDR | 1.92432947 |
19 | SYK | 1.78472548 |
20 | IKBKB | 1.74669820 |
21 | MAP3K12 | 1.69684535 |
22 | IRAK3 | 1.65667302 |
23 | ITK | 1.64441920 |
24 | CSF1R | 1.54427216 |
25 | TGFBR2 | 1.53598898 |
26 | LCK | 1.52511315 |
27 | HCK | 1.48553183 |
28 | MAP2K3 | 1.47861960 |
29 | JAK1 | 1.44718824 |
30 | ERN1 | 1.44002005 |
31 | CSK | 1.42198322 |
32 | STK10 | 1.41282875 |
33 | LYN | 1.37010470 |
34 | BMPR2 | 1.32526780 |
35 | FES | 1.29272729 |
36 | PIM1 | 1.26363006 |
37 | RPS6KA4 | 1.24050019 |
38 | FLT3 | 1.20303349 |
39 | PRPF4B | 1.18364155 |
40 | TAOK3 | 1.15958196 |
41 | LRRK2 | 1.14732383 |
42 | MKNK2 | 1.13546686 |
43 | NLK | 1.07508240 |
44 | MAP2K2 | 1.05545736 |
45 | CLK1 | 1.00700816 |
46 | FGFR4 | 0.95623580 |
47 | VRK2 | 0.95083068 |
48 | TGFBR1 | 0.94142079 |
49 | GRK6 | 0.89927738 |
50 | CHUK | 0.89725017 |
51 | TESK2 | 0.89117605 |
52 | MAP3K1 | 0.87867627 |
53 | MAPK7 | 0.85648580 |
54 | MAP3K11 | 0.82535900 |
55 | BCKDK | 0.80211684 |
56 | MST4 | 0.78647377 |
57 | MATK | 0.76710331 |
58 | FGFR3 | 0.76639907 |
59 | ADRBK2 | 0.74833411 |
60 | NEK9 | 0.74576673 |
61 | MAP2K6 | 0.74078973 |
62 | JAK2 | 0.72520657 |
63 | TNK2 | 0.71987347 |
64 | CAMKK2 | 0.70646104 |
65 | ARAF | 0.70160719 |
66 | ACVR1B | 0.70017692 |
67 | MOS | 0.68958691 |
68 | EPHB1 | 0.68121513 |
69 | MAP3K13 | 0.67183420 |
70 | TRPM7 | 0.66103101 |
71 | CDC42BPA | 0.63797710 |
72 | TLK1 | 0.61506344 |
73 | PTK2B | 0.60400274 |
74 | MARK3 | 0.57702582 |
75 | PKN2 | 0.57677860 |
76 | MAP3K3 | 0.54686751 |
77 | MAPK12 | 0.54414527 |
78 | PRKD2 | 0.54169163 |
79 | PRKCD | 0.54041069 |
80 | HIPK2 | 0.53760737 |
81 | EIF2AK3 | 0.53313130 |
82 | PAK4 | 0.53293790 |
83 | STK4 | 0.51401410 |
84 | PBK | 0.50239853 |
85 | STK16 | 0.50216758 |
86 | YES1 | 0.49554564 |
87 | BMX | 0.48486091 |
88 | PRKG2 | 0.48295306 |
89 | PDK1 | 0.47997290 |
90 | MUSK | 0.47813257 |
91 | ABL1 | 0.46867827 |
92 | SMG1 | 0.46370162 |
93 | MAPK11 | 0.46336782 |
94 | MYLK | 0.46109228 |
95 | PRKCQ | 0.45795551 |
96 | MAP3K5 | 0.45605517 |
97 | MAP3K8 | 0.44588891 |
98 | GRK7 | 0.44527258 |
99 | EIF2AK2 | 0.44070861 |
100 | ABL2 | 0.42210110 |
101 | MKNK1 | 0.41723682 |
102 | CDK4 | 0.41663695 |
103 | EEF2K | 0.41369437 |
104 | SIK3 | 0.40728013 |
105 | SCYL2 | 0.38709502 |
106 | IRAK1 | 0.38415430 |
107 | TAOK2 | 0.38098657 |
108 | RPS6KA6 | 0.37349207 |
109 | TESK1 | 0.36738138 |
110 | CDK6 | 0.36730787 |
111 | MAPKAPK2 | 0.36393103 |
112 | TIE1 | 0.35606151 |
113 | EIF2AK1 | 0.34707953 |
114 | MAPKAPK3 | 0.32811562 |
115 | MAPK4 | 0.31737454 |
116 | ILK | 0.31403372 |
117 | EGFR | 0.30815673 |
118 | TNIK | 0.29451859 |
119 | PDPK1 | 0.29422839 |
120 | RIPK1 | 0.28146665 |
121 | FYN | 0.27989555 |
122 | RPS6KA5 | 0.26411267 |
123 | PAK1 | 0.26400874 |
124 | FGR | 0.25835878 |
125 | IGF1R | 0.25637645 |
126 | VRK1 | 0.25581990 |
127 | DAPK1 | 0.23663951 |
128 | PIK3CG | 0.23431146 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.04874861 |
2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.90665684 |
3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.81195543 |
4 | Allograft rejection_Homo sapiens_hsa05330 | 2.59370979 |
5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.58980167 |
6 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.44845467 |
7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.35142366 |
8 | Measles_Homo sapiens_hsa05162 | 2.34446510 |
9 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.26881602 |
10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.22331635 |
11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.21976838 |
12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.17579687 |
13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.17228996 |
14 | Asthma_Homo sapiens_hsa05310 | 2.15896769 |
15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.08803478 |
16 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.08441371 |
17 | Legionellosis_Homo sapiens_hsa05134 | 1.97191527 |
18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.96378402 |
19 | Malaria_Homo sapiens_hsa05144 | 1.93760229 |
20 | Pertussis_Homo sapiens_hsa05133 | 1.80634645 |
21 | Other glycan degradation_Homo sapiens_hsa00511 | 1.75061622 |
22 | Tuberculosis_Homo sapiens_hsa05152 | 1.71465400 |
23 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.69306379 |
24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.64413133 |
25 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.61466377 |
26 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.57072048 |
27 | Ribosome_Homo sapiens_hsa03010 | 1.56690273 |
28 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.53698409 |
29 | Shigellosis_Homo sapiens_hsa05131 | 1.47715487 |
30 | Lysosome_Homo sapiens_hsa04142 | 1.46527310 |
31 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.43962002 |
32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.43921840 |
33 | Salmonella infection_Homo sapiens_hsa05132 | 1.43563100 |
34 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.42834026 |
35 | DNA replication_Homo sapiens_hsa03030 | 1.41534941 |
36 | Influenza A_Homo sapiens_hsa05164 | 1.39783236 |
37 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.39247815 |
38 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.31936568 |
39 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.27993241 |
40 | Apoptosis_Homo sapiens_hsa04210 | 1.27896193 |
41 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.27029545 |
42 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.26835318 |
43 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.26346422 |
44 | Viral myocarditis_Homo sapiens_hsa05416 | 1.26078156 |
45 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.20057274 |
46 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.18881422 |
47 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.15618921 |
48 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.13903138 |
49 | Phagosome_Homo sapiens_hsa04145 | 1.11025802 |
50 | Hepatitis B_Homo sapiens_hsa05161 | 1.10525413 |
51 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.04318507 |
52 | Proteasome_Homo sapiens_hsa03050 | 0.99324742 |
53 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.95009996 |
54 | Platelet activation_Homo sapiens_hsa04611 | 0.94164317 |
55 | Base excision repair_Homo sapiens_hsa03410 | 0.93279690 |
56 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.92989229 |
57 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.80108957 |
58 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.79652114 |
59 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.78006500 |
60 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.77138727 |
61 | Mismatch repair_Homo sapiens_hsa03430 | 0.75563707 |
62 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.75306459 |
63 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.74316725 |
64 | Hepatitis C_Homo sapiens_hsa05160 | 0.70061839 |
65 | Homologous recombination_Homo sapiens_hsa03440 | 0.69658847 |
66 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.64218208 |
67 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.60122605 |
68 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.58497388 |
69 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.56795754 |
70 | HTLV-I infection_Homo sapiens_hsa05166 | 0.56632973 |
71 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.54577911 |
72 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.54204255 |
73 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.53787212 |
74 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.50624470 |
75 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.48757505 |
76 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.47141094 |
77 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.45002953 |
78 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.44651159 |
79 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.44647083 |
80 | Amoebiasis_Homo sapiens_hsa05146 | 0.44606219 |
81 | Protein export_Homo sapiens_hsa03060 | 0.44590035 |
82 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.43086984 |
83 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.43072449 |
84 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.42250111 |
85 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.40431598 |
86 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.39456934 |
87 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.38712168 |
88 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.37785046 |
89 | Spliceosome_Homo sapiens_hsa03040 | 0.35234481 |
90 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.34605976 |
91 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.34512337 |
92 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.34469757 |
93 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.33957021 |
94 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.33869642 |
95 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.33384993 |
96 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.33242449 |
97 | RNA polymerase_Homo sapiens_hsa03020 | 0.32806621 |
98 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.32354277 |
99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31994656 |
100 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.31200392 |
101 | Galactose metabolism_Homo sapiens_hsa00052 | 0.29703577 |
102 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.29127287 |
103 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.29027088 |
104 | Bladder cancer_Homo sapiens_hsa05219 | 0.28269471 |
105 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.26904416 |
106 | Endocytosis_Homo sapiens_hsa04144 | 0.26849533 |
107 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.26362567 |
108 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.25312780 |
109 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.25245907 |
110 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.24325862 |
111 | RNA degradation_Homo sapiens_hsa03018 | 0.23738133 |
112 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.23654257 |
113 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.23578938 |
114 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.20219508 |
115 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.19619535 |
116 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.19045856 |